CalciMedica Inc reports results for the quarter ended in December - Earnings Summary

Calcimedica

28/03/2024 12:22

* CalciMedica Inc  CALC.OQ  reported a quarterly adjusted
loss
of 23 cents​​ per share for the quarter ended in December.  The
mean expectation of four analysts for the quarter was for a loss
of 87 cents per share. Wall Street expected results to range
from $-1.14 to -60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * CalciMedica Inc's reported EPS for the quarter was a loss
of 23
cents​.
    * The company reported a quarterly loss of $4.15 million.
    * CalciMedica Inc shares had risen by 46.5% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 14% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CalciMedica Inc
is $17.00 
This summary was machine generated from LSEG data March 28 at
12:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.87          -0.23          Beat
 Sep. 30 2023      -1.14          -0.82          Beat
 Jun. 30 2023      -1.04          -1.11          Missed
 Mar. 31 2023      -0.73          -23.43         Missed